Breaking Down Eastman Chemical: 10 Analysts Share Their Views
Analysts' ratings for Eastman Chemical (NYSE:EMN) over the last quarter vary from bullish to bearish, as provided by 10 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 2 | 4 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 2 | 1 | 1 | 0 | 0 |
| 2M Ago | 1 | 1 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 1 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $73.5, a high estimate of $79.00, and a low estimate of $70.00. This current average has increased by 4.26% from the previous average price target of $70.50.
Investigating Analyst Ratings: An Elaborate Study
The standing of Eastman Chemical among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Stephen Richardson | Evercore ISI Group | Raises | In-Line | $75.00 | $70.00 |
| Patrick Cunningham | Citigroup | Raises | Buy | $78.00 | $75.00 |
| Jeffrey Zekaukas | JP Morgan | Raises | Overweight | $70.00 | $60.00 |
| David Begleiter | Deutsche Bank | Raises | Hold | $72.00 | $64.00 |
| Steve Byrne | B of A Securities | Raises | Buy | $79.00 | $74.00 |
| Arun Viswanathan | RBC Capital | Lowers | Sector Perform | $70.00 | $74.00 |
| Patrick Cunningham | Citigroup | Raises | Buy | $75.00 | $72.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $74.00 | $76.00 |
| Michael Sison | Wells Fargo | Maintains | Equal-Weight | $70.00 | $70.00 |
| Patrick Cunningham | Citigroup | Raises | Buy | $72.00 | $70.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Eastman Chemical. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Eastman Chemical compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Eastman Chemical's stock. This examination reveals shifts in analysts' expectations over time.
To gain a panoramic view of Eastman Chemical's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Eastman Chemical analyst ratings.
Get to Know Eastman Chemical Better
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
Eastman Chemical: A Financial Overview
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Decline in Revenue: Over the 3M period, Eastman Chemical faced challenges, resulting in a decline of approximately -12.12% in revenue growth as of 31 December, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Eastman Chemical's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 5.32%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Eastman Chemical's ROE excels beyond industry benchmarks, reaching 1.79%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.7%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.8.
Analyst Ratings: Simplified
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.